Effects of tumor necrosis factor-(TNF) and interferon-Á (IFNÁ) on gene expression profiles in bladder carcinoma cells using oligonucleotide microarray analysis

Cancer Genomics and Proteomics

Volumn 1, Issue 5-6, 2004, Pages 455-464

  Champelovier, Pierre ^a   El Atifi, Michele ^b   Mantel, Frederic ^b   Michallat, Sandrine ^b   Simon, Annick ^c   Rostaing, Béatrice ^b   Berger, Francois ^b   Seigneurin, Daniel ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL MICHALLON   (France)

Author keywords

IFN ; Microarray; Survival; TNF

Indexed keywords

EID: 27144491913     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Morales A, Eidinger D and Bruce AW: Intracavity bacillus Calmette Guerin in the treatment of superficial bladder tumors. J Urol 116: 180-186, 1976.
2. Herr H, Laudone VP and Badalement RA: Bacillus Calmette Guerin therapy alters the progression of superficial bladder cancer. J Clin Oncol 6: 1450-1455, 1988.
3. Patard JJ, Saint F, Velotti F, Abbou CC and Chopin DK: Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review. Urol Res 26: 155-159, 1998.
4. Prescott S, James K and Hargreave TB: Radiommunoassay detection of interferon-gamma in urine after intravesical BCG therapy. J Urol 144: 1248-1252, 1990.
5. De Boer EC, De Jong WH and Steerenberg PA: Induction of interleukins-1 (IL-1), IL-2, IL-6 and tumor necrosis factor during intravesical immunotherapy with bacillus Calmette Guerin in superficial bladder cancer. Cancer Immunol Immunoth 34: 306-311, 1992.
6. Park DS, Park JH, Lee JL, Lee JM, Kim YH, Lee JM and Kim SJ: Induction of ICAM-1, HLA-DR molecules by IFN-gamma and oncogene expression in human bladder cancer cell lines. Urol Int 59: 72-80, 1997.
7. Hawkyard SJ, Jackson AM, James K, Prescott S, Smyth JF and Chisholm GD: The inhibitory effects of interferon gamma on the growth of bladder cancer cells. J Urol 147: 1399-1403, 1992.
8. Stavropoulos NE, Hastazeris K, Filiadis I, Milhailidis I, Ioachim E, Liamis Z and Kalomiris P: Intravesical instillation of interferon gamma in the prophylaxis of high risk superficial bladder cancer. Scand J Urol Nephrol 36: 218-222, 2001.
9. Giannopoulos A, Constantinides C, Fokaeas E, Stravodimos C, Giannopoulos M, Kyroudi A and Gounaris A: The immunomodulating effect of interferon-Á intravesical instillations in preventing bladder cancer recurrence. Clin Cancer Res 9: 5550-5558, 2003.
10. Kelly SA, Gschmeissner S, East N and Balkwill FR: Enhancement of metastatic potential by Á-interferon. Cancer Res 51: 4020-4027, 1991.
11. Champelovier P, Simon A, Garrel C, Levacher G, Praloran V and Seigneurin D: Is interferon Á one key of metastatic potential increase in human bladder carcinoma ? Clin Cancer Res 9: 4562-4569, 2003.
12. Matsuura K, Otsuka F and Fujisawa H: Effects of interferons on tumor necrosis factor production from human keratinocytes. Cytokine 10: 500-505, 1998.
13. Masafumi T, Yum K and Vilcek J: Interferon-Á enhances expression of cellular receptors for tumor necrosis factor. J Immunol 136: 2441-2444, 1996.
14. Fiers W: Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett 285: 199-212, 1991.
15. Himeno T, Watanabe N, Yamauchi N, Maeda M, Tsuji Y, Okamoto T, Neda H and Niitsu Y: Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res 50: 4941-4945, 1990.
16. Beg AA and Baltimore D: An essential role for NF-kB in preventing TNF-induced cell death. Science 274: 782-784, 1996.
17. Ito H, Kyo S, Kanaya T, Takakura M, Koshida K, Namiki M and Inoue M: Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Clin Cancer Res 4: 2807-2810, 1998.
18. Thykjaer T, Workman C, Kruhoffer M, Demtroder K, Wolf H, Andersen LD, Frederiksen CM, Knudsen S and Orntoft TF: Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res 61: 2492-2499, 2001.
19. Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G and Cordon-Cardo C: Molecular profiling of bladder cancer using cDNA microarrays : defining histogenesis and biological phenotypes. Cancer Res 62: 6973-6980, 2002.
20. Dyrskot L, Thykjaer T, Kruhoffer M, Jensen JL, Marcussen N, Hamilton-Dutoit S, Wolf H and Orntoft TF: Identifying distinct classes of bladder carcinoma using microarrays. Nature Genetics 33: 90-96, 2003.
21. Jansen BJH, van Ruissen F, de Jongh G, Zeeuwen PLJM and Schalkwijk J: Serial analysis of gene expression in differentiated cultures of human epidermal keratinocytes. J Invest Dermatol 116: 12-22, 2001.
22. Gallagher J, Howlin J, McCarthy C, Murphy EP, Bresnihan B, Fitzgerald O, Godson C, Brady HR and Martin F: Identification of Naf1/ABIN-1 among TNF-induced expressed genes in human synoviocytes using oligonucleotide microarrays. FEBS Lett 551: 8-12, 2003.
23. Der SD, Zhou A, Williams BRG and Silverman RH: Identification of genes differentially regulated by interferon , ' or Á using oligonucleotid arrays. Proc Natl Acad Sci USA 95: 15623-15628, 1998.
24. Patrone L, Damore MA, Lee MB, Malone CS and Wall R: Genes expressed during the IFNÁ-induced maturation of pre-B cells. Mol Immunol 38: 597-606, 2001.
25. El Atifi M, Dupré I, Rostaing B, Benabid AL and Berger F: Quantification of DNA probes on nylon microarrays using T4 polynucleotide kinase labeling. BioTechniques 35: 262-266, 2003.
26. El Atifi M, Dupré I, Rostaing B, Chambaz EM, Benabid AL and Berger F: Long oligonucleotide arrays on nylon for large-scale gene expression analysis. BioTechniques 33: 612-618, 2002.
27. Monier F, Mollier S, Guillot M, Rambeaud JJ, Morel F and Zaoui P: Urinary release of 72 and 92 kDa gelatinases, TIMPs, N-GAL and conventional prognostic factors in urothelial carcinomas. Eur Urol 42: 356-363, 2002.
28. Shirahama T, Arima J-I, Akiba S and Sakakura C: Relationship between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. Cancer 92: 188-193, 2001.
29. Shariat S, Matsumoto K, Kim J, Ayala GE, Zhou J-H, Jian W, Benedict WF and Lerner SP: Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder. J Urol 170: 985-989, 2003.
30. Bidgood MJ, Jamal OS, Cunningham AM, Brooks PM and Scott KF: Type IIA secretory phospholypase A2 up-regulates cycloo-xygenase-and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. J Immunol 165: 2790-2797, 2000.
31. Fidler IJ and Hart IR: Biologic diversity in metastatic neoplasm-origins and implications. Science (Washington DC) 217: 998-1001, 1982.
32. Herr HW: Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin. J Urol 145: 40-45, 1991.
33. Sanchez-Carbayo M, Socci ND, Lozano JJ, Li W, Charytonowicz E, Belbin TJ, Prystowsky M, Ortiz AR, Childs G and Cordon-Cardo C: Gene discovery in bladder cancer progression using cDNA microarray. Am J Pathol 163: 505-516, 2003.
34. Balbay D, Ozen H, Ozkardes H, Barut A, Bakkaloglu M, Tasar C and Remzi D: Detection of urinary interleukin-2, interleukin-2 receptor, and tumor necrosis factor levels in patients with superficial bladder tumors after intravesical BCG immunotherapy. Urology 43: 187-190, 1994.
35. Hawkyard SJ, Jackson AM, James K, Prescott S, Smyth JF and Chisholm GD: The inhibitory effects of interferon gamma on the growth of bladder cancer cells. J Urol 147: 1399-1403, 1992.
36. Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radin R and Dinney CP: Interleukin 8 expression regulates tumorigenesis and metastasis in human bladder cancer. Cancer Res 60: 2290-2299, 2000.
37. Guenzi E, Topolt K, Luberseder-Martellato C, Jorg A, Naschberger E, Benelli R, Albini A and Sturzl M: The guanylate binding protein-GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J 22: 3772-3782, 2003.
38. Bostom PJ, Ravanti L, Reunanen V, Soderstrom KO, Kahari VM and Laato M: Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer 88: 417-423, 2000.
39. Staack A, Koenig F, Daniltchenko D, Hauptmann S, Loening SA, Schnorr D and Jung K: Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder. Urology 59: 308-312, 2002.
40. Izawa JI, Slaton JW, Kedar D, Karashima T, Perrotte P, Czerniak B, Grossman HB and Dinney CP: Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder. Oncol Rep 8: 9-15, 2001.
41. Xie DH, Tang XD, Xia SJ, Tan JM, Wang XH and Cai Y: Expression of NF-kappa B in human bladder cancer and its clinical significance. Ai Zheng 21: 663-667, 2002.
42. Shirahama T, Arima J, Akiba S and Sakakura C: Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the bladder. Cancer 92: 188-193, 2001.
43. Litchfield DW: Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochemical J 369: 1-15, 2003.
44. Park J-W, Jang M-A, Lee YH, Passanniti A and Kwon TK: p53-independent elevation of p21 expression by PMA results from PKCmediated mRNA stabilization. Biochem Biophysic Res Com 280: 244-248, 2001.
45. Patard JJ, Saint F, Velotti F, Abbou CC and Chopin DK: Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review. Urol Res 26: 155-159, 1998.
46. Anderson L and Seilhaer J: A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18: 533-537, 1997.
47. Verhoeckx K, Bijlsma S, de Groene E, Witkamp R, van der Greef J and Rodenburg R: A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. Proteomics 4: 1014-1028, 2004.
48. Orntoft TF, Thykjaer T, Waldman FM, Wolf H and Celis JE: Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol Cell Proteomics 1: 37-45, 2002.